Evolution and Emergence of Pathogenic Viruses: Past, Present, and Future

Intervirology

Volumn 60, Issue 1-2, 2017, Pages 1-7

  Parvez, Mohammad K ^a   Parveen, Shama ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Emerging infections; Novel viruses; Viral outbreaks; Virus evolution

Indexed keywords

ADAPTATION; HOST; HUMAN; INFECTION CONTROL; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRAL PHENOMENA AND FUNCTIONS; VIRUS; VIRUS EMERGENCE; VIRUS EVOLUTION; ANIMAL; CHIKUNGUNYA; COMMUNICABLE DISEASE; EPIDEMIC; GENETICS; INFLUENZA; MOLECULAR EVOLUTION; ORTHOMYXOVIRUS INFECTION; PATHOGENICITY; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VIROLOGY; VIRUS INFECTION; WILD ANIMAL; ZIKA FEVER; ZOONOSIS;

ANIMALS; ANIMALS, WILD; CHIKUNGUNYA FEVER; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; EVOLUTION, MOLECULAR; HUMANS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE INFECTIONS; VIRUS DISEASES; VIRUSES; ZIKA VIRUS INFECTION; ZOONOSES;

EID: 85026882793     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000478729     Document Type: Review

References (63)

1. Krause RM: The origin of plagues: old and new. Science 1992; 257: 1073-1078.
2. Wever PC, van Bergen L: Death from 1918 pandemic influenza during the First World War: A perspective from personal and anecdotal evidence. Influenza Other Respir Viruses 2014; 8: 538-546.
3. Dawood FS, Iuliano AD, Reed C, et al: Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study. Lancet Infect Dis 2012; 12: 687-695.
4. WHO: Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. http://www. who. int/csr/sars/country/ table2004-04-21/en/.
5. Gardner SD, Field AM, Coleman DV, Hulme B: New human papovavirus (B. K.) isolated from urine after renal transplantation. Lancet 1971; 1: 1253-1257.
6. Padgett BL, Walker DL, ZuRhein GM et al. : Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1: 1257-1260.
7. Feng H, Shuda M, Chang Y, Moore PS: Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-1100.
8. Paweska T, Sewlall NH, Ksiazek TG, et al: Nosocomial outbreak of novel arenavirus infection, southern Africa. Emerg Infect Dis 2009; 15: 1598-1602.
9. WHO: Lassa fever fact sheet 2016. http:// www. who. int/mediacentre/factsheets/fs179/ en/.
10. Lu S, Xi X, Zheng Y, et al: Analysis of the clinical characteristics and treatment of two patients with avian influenza virus (H7N9). Biosci Trends 2013; 7: 109-112.
11. Khan G: A novel coronavirus capable of lethal human infections: An emerging picture. Virol J 2013; 10: 66-65.
12. Musso D, Gubler DJ: Zika Virus. Clin Microbiol Rev 2016; 29: 487-524.
13. Cleaveland S, Laurenson MK, Taylor LH: Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence. Phil Trans R Soc Lond B 2011; 356: 991-999.
14. Taylor LH, Latham SM, Woolhouse MEJ: Risk factors for human disease emergence. Phil Trans R Soc Lond B 2013; 356: 983-989.
15. Woolhouse MEJ, Gowtage-Sequeria S: Host range and emerging and re-emerging pathogens. Emerg Infect Dis 2005; 11: 1842-1847.
16. Kilpatrick AM, Randolph SE: Drivers, dynamics, and control of emerging vectorborne zoonotic diseases. Lancet 2012; 380: 1946-1955.
17. Cleaveland S, Haydon DT, Taylor L: Overviews of pathogen emergence: which pathogens emerge, when and why Curr Top Microbiol Immunol 2007; 315: 85-111.
18. Corman VM, Eckerle I, Bleicker T, et al: Detection of a novel human coronavirus by realtime reverse-transcription polymerase chain reaction. Euro Surveill 2012; 17:pii: 20285.
19. Anderson LJ, Tong S: Update on SARS research and other possibly zoonotic coronaviruses. Int J Antimicrob Agents 2010; 36:S21-S25.
20. McElhinney LM, Marston DA, Leech S, et al: Molecular epidemiology of bat lyssaviruses in europe. Zoo Pub Health 2013; 60: 35-45.
21. McCall BJ, Epstein JH, Neill AS, et al: Potential exposure to Australian bat lyssavirus, Queensland, 1996-1999. Emerg Infect Dis 2000; 6: 259-264.
22. Allworth A, Murray K, Morgan J: A human case of encephalitis due to a Lyssavirus recently identified in fruit bats. Commun Dis Intell 1996; 20: 504-510.
23. Hanna JN, Carney IK, Smith GA, et al: Australian bat lyssavirus infection: A second human case, with a long incubation period. Med J Aust 2000; 172: 597-599.
24. Fooks A: The challenge of new and emerging lyssaviruses. Expert Rev Vaccines 2004; 3: 333-336.
25. CDC: Rodents in the United States that carry hantavirus. http://www. cdc. gov/hantavirus/ rodents/index. html.
26. Ge X, Yang W, Pan H, et al: Fugong virus, a novel hantavirus harbored by the small oriental vole ( Eothenomys eleusis) in China. Virol J 2016; 13: 27-32.
27. Pavio N, Meng XJ, Doceul V: Zoonotic origin of hepatitis E. Curr Opin Virol 2015; 10: 34-41.
28. Widén F: Hepatitis E as a zoonosis. Adv Exp Med Biol 2016; 948: 61-71.
29. Spandole S, Cimponeriu D, Berca LM, Mihescu G: Human anelloviruses: An update of molecular, epidemiological and clinical aspects. Arch Virol 2015; 160: 893-908.
30. Duffy M R, ChenT-H, et al: Zika virus outbreak on Yap Island, Federated States of Micronesia. New Eng J Med 2009; 360: 2536-2543.
31. PAHO: Regional Zika epidemiological update (Americas) 2016. http://www. paho. org/ hq/index. phpoption=com-content&id= 11599&Itemid=41691.
32. Pesko KN, Ebel GD: West Nile virus population genetics and evolution. Infect Genet Evol 2012; 12: 181-190.
33. Mertens M, Schmidt K, Ozkul A, Groschup MH: The impact of Crimean-Congo hemorrhagic fever virus on public health. Antiviral Res 2013; 98: 248-260.
34. Yu XJ, Liang MF, Zhang SY, et al: Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med 2011; 364: 1523-1532.
35. Simmonds P: Reconstructing the origins of human hepatitis viruses. Phil Trans R Soc Lond B 2011; 356: 1013-1026.
36. Kitchen A, Shackelton LA, Holmes EC: Family level phylogenies reveal modes of macroevolution in RNA viruses. Proc Natl Acad Sci USA 2011; 108: 238-243.
37. Wolfe ND, Dunavan CP, Diamond J: Origins of major human infectious diseases. Nature 2007; 447: 279-283.
38. Woolhouse MEJ, Adair K: The diversity of human viruses. Future Virol 2013; 8: 159-171.
39. Shukla P, Nguyen HT, Torian U, et al: Crossspecies infections of cultured cells by hepatitis E virus and discovery of an infectious virushost recombinant. Proc Natl Acad Sci USA 2011; 108: 2438-2443.
40. Grenfell BT, Pybus OG, Gog JR, et al: Unifying the epidemiological and evolutionary dynamics of pathogens. Science 2004; 303: 327-332.
41. Holmes EC: The Evolution and Emergence of RNA Viruses. Oxford, Oxford University Press, 2009.
42. Tsetsarkin KA, Weaver SC: Sequential adaptive mutations enhance efficient vector switching by chikungunya virus and its epidemic emergence. PLoS Pathog 2011; 7:e1002412.
43. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S: A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 2007; 3:e201.
44. Abushouk AI, Negida A, Ahmed H: An updated review of Zika virus. J Clin Virol 2016; 84: 53-58.
45. Trento A, Galiano M, Videla C, Carballal G, Garcia-Barreno B, et al: Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. J Gen Virol 2003; 84: 3115-3120.
46. Eshaghi A, Duvvuri VR, Lai R, Nadarajah JT, Li A, et al: Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: A novel genotype with a 72 nucleotide G gene duplication. PLoS One 2012; 7:e32807.
47. Ahmed A, Haider SH, Parveen S, et al: Cocirculation of 72-bp duplication group A and 60-bp duplication group B respiratory syncytial virus (RSV) strains in Riyadh, Saudi Arabia during 2014. PLoS One 2016; 11:e0166145
48. Duvvuri VR, Granados A, Rosenfeld P, Bahl J, Eshaghi A, et al: Genetic diversity and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local transmission dynamics. Sci Rep 2015; 5: 14268.
49. Trento A, Casas I, Calderon A, Garcia-Garcia ML, Calvo C, et al: Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene. J Virol 2010; 84: 7500-7512.
50. Parveen S, Sullender WM, Fowler K, Lefkowitz EJ, Kapoor SK, Broor S: Genetic variability in the G protein gene of group A and B respiratory syncytial viruses from India. J Clin Microbiol 2006; 44: 3055-3064.
51. Anderson RM, Fraser C, Ghani AC, et al: Epidemiology, transmission dynamics and control of SARS: The 2002-2003 epidemic. Phil Trans R Soc Lond B 2004; 359: 1091-1105.
52. Hufnagel L, Brockmann D, Geisel T: Forecast and control of epidemics in a globalized world. Proc Natl Acad Sci USA 2004; 101: 15124-15129.
53. Kucharski AJ, Funk S, Eggo RM, et al: Transmission dynamics of Zika virus in island populations: A modeling analysis of the 2013-14 French Polynesia outbreak. PLoS Negl Trop Dis 2016; 10:e0004726.
54. Li WD, Shi ZL, Yu M, et al: Bats are natural reservoirs of SARS-like coronaviruses. Science 2005; 310: 676-679.
55. Guan Y, Zheng BJ, He YQ, et al: Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003; 302: 276-278.
56. Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P, et al: Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol 2001; 75: 10290-10299.
57. Deeba F, Islam A, Kazim SN, Naqvi IH, Broor S, Ahmed A, Parveen S: Chikungunya virus: recent advances in epidemiology, host pathogen interaction and vaccine strategies. Pathog Dis 2016; 74:ftv119.
58. Parvez MK: Chronic hepatitis E infection: risks and controls. Intervirol 2013; 56: 213-216.
59. French CE, McKenzie BC, Coope C, et al: Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: A systematic review. Influenza Other Respir Viruses 2016; 10: 268-290.
60. Afreen N, Naqvi IH, Baroor S, Ahmed A, Parveen S: Phylogenetic and molecular clock analysis of dengue serotype 1 and 3 from New Delhi, India. PLoS One 2015; 10:e0141628.
61. Tazeen A, Afreen N, Abdullah M, et al: Occurrence of co-infection with dengue viruses during 2014 in New Delhi, India. Epidemiol Infect 2016; 13: 1-11.
62. Lahariya C, Pradhan S: Emergence of chikungunya virus in Indian subcontinent after 32 years: A review. J Vector borne Dis 1996; 43: 151-157.
63. Afreen N, Deeba F, Khan WH, et al: Molecular characterization of dengue and chikungunya virus strains circulating in New Delhi, India. Microbiol Immunol 2014; 58: 688-696.